r 64719 has been researched along with 8-cyclopentyl-1,3-dimethylxanthine in 1 studies
| Studies (r 64719) | Trials (r 64719) | Recent Studies (post-2010) (r 64719) | Studies (8-cyclopentyl-1,3-dimethylxanthine) | Trials (8-cyclopentyl-1,3-dimethylxanthine) | Recent Studies (post-2010) (8-cyclopentyl-1,3-dimethylxanthine) |
|---|---|---|---|---|---|
| 15 | 0 | 0 | 273 | 0 | 30 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boissard, CG; Gribkoff, VK | 1 |
1 other study(ies) available for r 64719 and 8-cyclopentyl-1,3-dimethylxanthine
| Article | Year |
|---|---|
The effects of the adenosine reuptake inhibitor soluflazine on synaptic potentials and population hypoxic depolarizations in area CA1 of rat hippocampus in vitro.
Topics: Adenosine; Animals; Hippocampus; Hypoxia, Brain; In Vitro Techniques; Male; Piperazines; Rats; Rats, Inbred F344; Synapses; Synaptic Transmission; Theophylline | 1993 |